TP53 and breast carcinoma: We have shown here that the expression of oncomotif-miRNAs in both LUAD and breast cancer is significantly higher in tumors harboring TP53 mutations, indicating that the oncogenic signaling including oncomotif-miRNAs is tolerated in cells with the apoptotic machinery inactivated.